GlassScriptPhysician profile
Leslie W Levenson
NPI 1689630717
$5,749.01
in general payments reported to CMS, 2019-2025
34 companies · $1,402 in 2025
The $1,402 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $217 · 2021: $594 · 2022: $732 · 2023: $806 · 2024: $1,122 · 2025: $1,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,330.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,037.26 | 2019-2025 | |
| Amgen INC. | $586.48 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $552.41 | 2021-2025 | Micra, Resolute Onyx |
| Boston Scientific Corporation | $402.87 | 2021-2025 | Cds - Mct/Cem Monitoring, Watchman Flx |
| Biotronik INC. | $317.61 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $277.04 | 2022-2025 | Assure Wcd |
| Medtronic Vascular, INC. | $276.97 | 2019-2020 | |
| Sirtex Medical INC | $268.42 | 2022-2023 | Sir-Spheres Microspheres |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $235.71 | 2021-2024 | Lifevest |
| Philips North America LLC | $201.97 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| E.R. Squibb & Sons, L.L.C. | $189.64 | 2019-2025 | Eliquis, Camzyos |
| Alnylam Pharmaceuticals INC. | $174.79 | 2022-2025 | Onpattro |
| Abbott Laboratories | $147.53 | 2025 | Gallant, Cardiomems, Accent |
| Pfizer INC. | $147.37 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $139.30 | 2020-2024 | Xarelto |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $87.11 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $66.67 | 2020-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.56 | 2022-2025 | Jardiance |
| Novo Nordisk INC | $61.19 | 2023 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $58.32 | 2023-2024 | Verquvo |
| Preventice Services, LLC | $52.50 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $50.11 | 2019-2021 | |
| Edwards Lifesciences Corporation | $49.87 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Regeneron Healthcare Solutions, INC. | $49.79 | 2019 | |
| Cvrx, INC. | $49.05 | 2023 | Barostim Neo System |
| Irhythm Technologies, INC. | $32.35 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Shockwave Medical, INC | $27.82 | 2025 | |
| Sanofi-Aventis U.S. LLC | $26.70 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $25.38 | 2024 | |
| Atricure, INC. | $20.45 | 2023 | |
| Scpharmaceuticals INC. | $19.89 | 2025 | |
| Amarin Pharma, INC. | $19.11 | 2022 | |
| Inspire Medical Systems, INC. | $18.97 | 2024 | Inspire |
| Actelion Pharmaceuticals US, INC. | $16.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Levenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.